The Mountain State is about to put its Medicaid population on a diet run by the weight-loss company in an attempt to reduce the $100 million a year it spends in obesity-related medical costs. Helen Palmer reports.
AIDS activists took to the streets of Washington, D.C., and New Delhi, India today, protesting an attempt by Novartis to extend the patent protection for a new leukemia drug it makes. Shia Levitt reports.
GlaxoSmithKline may have covered up negative findings during clinical trials that linked its antidepressant drug Seroxat with suicidal feelings in teens. Stephen Beard reports.
He's the executive. He gets to give the orders. Earlier this month President Bush issued an executive order that should make businesses pretty happy. Stephen Henn reports.
Would you pay to store stem cells from your newborn's umbilical cord, just in case? British entrepreneur Richard Branson wants to start a company that offers just such a service. Stephen Beard reports.
Wealthy and well-intentioned philanthropists are changing the face of global health care, but not necessarily to a greater good. Council on Foreign Relations senior fellow Laurie Garrett explains how the world is missing the big picture.
Consumer advocate Jamie Court says President Bush's proposal to tax healthcare spending above what the government thinks is too much is a raw deal for consumers who have no control over their insurance bills.
In an attempt to prevent doctors involved in clinical cancer trials from leaking results to investment firms, one medical group has put a new policy in place. Janet Babin has details.
Every new public policy creates its winners and its losers. Commentator Robert Reich says, when it comes to making winners of consumers, the president's healthcare proposal falls short.
